Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, Sold Out, 2024 Q2

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Sold out

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q2 2024: Stock AVADEL PHARMACEUTICALS PLC; Country of operation —; Class SPONSORED ADR; Shares before 1,563,890.
  • Q2 2024: Stock TDCX INC; Country of operation —; Class ADS; Shares before 529,775.
  • Q2 2024: Stock DADA NEXUS LTD; Country of operation —; Class ADS; Shares before 337,013.
  • Q2 2024: Stock AMARIN CORP PLC; Country of operation —; Class SPONS ADR NEW; Shares before 592,779.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2024AVADEL PHARMACEUTICALS PLC
CUSIP 05337M104
—SPONSORED ADR1,563,8900-1,563,890$26,414,102$0-$26,414,1022024-08-14
Q2 2024TDCX INC
CUSIP 87190U100
—ADS529,7750-529,775$3,798,487$0-$3,798,4872024-08-14
Q2 2024DADA NEXUS LTD
CUSIP 23344D108
—ADS337,0130-337,013$690,877$0-$690,8772024-08-14
Q2 2024AMARIN CORP PLC
CUSIP 023111206
—SPONS ADR NEW592,7790-592,779$528,048$0-$528,0482024-08-14
Q2 2024CHIPMOS TECHNOLOGIES INC
CUSIP 16965P202
TaiwanSPONSORD ADS NEW12,4160-12,416$390,483$0-$390,4832024-08-14
Q2 2024CALLIDITAS THERAPEUTICS AB
CUSIP 13124Q106
—SPONSERED ADS14,5940-14,594$315,960$0-$315,9602024-08-14
Q2 2024NEXXEN INTERNATIONAL LTD
CUSIP 89484T104
—SPON ADR23,9610-23,961$125,076$0-$125,0762024-08-14
Q2 2024UNILEVER PLC
CUSIP 904767704
—SPON ADR NEW2,3960-2,396$120,255$0-$120,2552024-08-14
Q2 2024DBV TECHNOLOGIES S A
CUSIP 23306J101
—SPONSORED ADR152,0190-152,019$114,881$0-$114,8812024-08-14
Q2 2024OLINK HLDG AB
CUSIP 680710100
—SPONSORED ADS2,8600-2,860$67,239$0-$67,2392024-08-14
Q2 2024MORPHOSYS AG
CUSIP 617760202
—SPONSORED ADS3,5940-3,594$65,195$0-$65,1952024-08-14
Q2 2024GENFIT S A
CUSIP 372279109
—ADS16,8330-16,833$59,925$0-$59,9252024-08-14
Q2 2024BANCO BRADESCO S A
CUSIP 059460402
—SPONSORED ADR22,6930-22,693$58,094$0-$58,0942024-08-14
Q2 2024STEAKHOLDER FOODS LTD
CUSIP 583435102
—SPONSORED ADS83,7400-83,740$48,904$0-$48,9042024-08-14
Q2 2024WARRANTEE INC
CUSIP 93465C106
—SPON ADS86,5750-86,575$42,422$0-$42,4222024-08-14
Q2 2024ALTERITY THERAPEUTICS LTD
CUSIP 02155X205
AustraliaSPONSORED ADS18,2790-18,279$37,472$0-$37,4722024-08-14
Q2 2024ADAGENE INC
CUSIP 005329107
Cayman IslandsADS12,9950-12,995$36,646$0-$36,6462024-08-14
Q2 2024CAN FITE BIOFARMA LTD
CUSIP 13471N300
—SPONSORED ADR14,1710-14,171$31,460$0-$31,4602024-08-14
Q2 2024EVAXION BIOTECH A/S
CUSIP 29970R204
—SPONSORED ADS8,1410-8,141$26,051$0-$26,0512024-08-14
Q2 2024NUCANA PLC
CUSIP 67022C106
—SPONSORED ADR89,3440-89,344$23,229$0-$23,2292024-08-14
Q2 2024HUIZE HLDG LTD
CUSIP 44473E105
—SPONSORED ADS34,0610-34,061$19,943$0-$19,9432024-08-14
Q2 2024ZHIHU INC
CUSIP 98955N108
—ADS25,2580-25,258$17,274$0-$17,2742024-08-14
Q2 2024GRAPHEX GROUP LTD
CUSIP 38867H104
—SPONSORED ADS44,7760-44,776$13,934$0-$13,9342024-08-14
Q2 2024QUOIN PHARMACEUTICALS LTD
CUSIP 74907L300
—SPONSORED ADS10,7860-10,786$10,226$0-$10,2262024-08-14
Q2 2024BURNING ROCK BIOTECH LTD
CUSIP 12233L107
—SPONSORED ADS12,5580-12,558$9,157$0-$9,1572024-08-14
Q2 2024FANGDD NETWORK GROUP LTD
CUSIP 30712L307
—SPONSORED ADS18,6840-18,684$8,406$0-$8,4062024-08-14
Q2 2024SCINAI IMMUNOTHERAPEUTICS LT
CUSIP 09073Q204
—SPON ADS NEW12,2140-12,214$6,310$0-$6,3102024-08-14
Q2 2024ARGO BLOCKCHAIN PLC
CUSIP 040126104
—ADS1,7840-1,784$3,871$0-$3,8712024-08-14
Q2 2024AESTHETIC MED INTL HLDG GR L
CUSIP 00809M104
—ADS11,3630-11,363$3,523$0-$3,5232024-08-14
Q2 2024FORESIGHT AUTONOMOUS HLDGS L
CUSIP 345523203
—SPONSORED ADR5820-582$623$0-$6232024-08-14